RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Operating margin (%)

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$108.9B
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 2024-2.1-105.44%
Dec 31, 202338.8-19.50%
Dec 31, 202248.2+31.31%
Dec 31, 202136.7-20.20%
Dec 31, 202046+59.99%
Dec 31, 201928.8+38.04%
Dec 31, 201820.8+320.84%
Dec 31, 20175+748.38%
Dec 31, 20160.6-101.29%
Dec 31, 2015-45.2-62.09%
Dec 31, 2014-119.3+60.04%
Dec 31, 2013-74.5-48912.60%
Dec 31, 20120.2-98.11%
Dec 31, 20118.1-101.66%
Dec 31, 2010-485.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)